The global Ophthalmic Surgical Market is expected to grow at a CAGR of 5.7% from 2024 to 2034. The market value is projected to increase from USD 13,937.8 million in 2024 to USD 24,194.2 million by 2034.
Attributes | Key Insights |
---|---|
Base Value, 2023 | USD 13,159.7 million |
Estimated Global Ophthalmic Surgical Market Size (2024E) | USD 13,937.8 million |
Projected Ophthalmic Surgical Market Value (2034F) | USD 24,194.2 million |
Value-based CAGR (2024 to 2034) | 5.7% |
The increasing frequency of retinal detachment, corneal transplants, and LASIK-laser refraction supports the ophthalmic surgical market expansion. Treating several ophthalmic conditions such as cataracts, glaucoma, diabetic retinopathy, macular degeneration, and vitrectomy requires surgery, which is expected to promote the market’s growth.
Advancements in ocular technology, such as high-definition scans and three-dimensional imaging, enable precise operations. This discovery and innovation are expected to enhance patient outcomes and create excellent market expansion opportunities. The growing pipeline of advanced ophthalmic surgeries is projected to surge the demand for ophthalmic surgeries.
A key factor propelling the market expansion is the rising prevalence of eye illnesses worldwide. The ophthalmic surgical device market is expanding due to new product introductions and technical developments. Over the projected period, government measures to help visually impaired populations are also anticipated to boost market expansion.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global ophthalmic surgical market recorded a historic CAGR of 5.3% from 2019 to 2023.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of the top five countries. The United States, Japan, and Germany are set to record high CAGRs of 8.3%, 8.1%, and 7.7%, respectively, through 2034.
Country | Value CAGR |
---|---|
United States | 8.3% |
Japan | 8.1% |
China | 7.1% |
Germany | 7.7% |
United Kingdom | 7.3% |
The United States is expected to exhibit a CAGR of 8.3% throughout the forecast period. Top factors supporting the market expansion in the country include:
Japan is expected to expand with a CAGR of 8.1% through 2034. This is attributable to a combination of factors, including:
China is expected to grow at a CAGR of 7.1% during the forecast period. The key factors supporting the ophthalmic surgical market growth are:
Sales of ophthalmic surgery in Germany are estimated to record a CAGR of 7.7% through 2034. The primary factors bolstering the ophthalmic surgical market size are:
The United Kingdom is predicted to register a compound annual growth rate of 7.3% during the forecast period.
The section below shows the consumable segment dominating by product type. It is predicted to surge at a CAGR of 5.3% by 2034. Based on the distribution channel, the ophthalmic clinics segment is anticipated to generate a dominant share through 2024. It is set to rise at a 5.3% CAGR by 2034.
Segment | Value CAGR |
---|---|
Consumable (Product Type) | 5.3% |
Ophthalmic Clinics (Distribution Channel) | 5.3% |
The market value of consumables in ophthalmic surgery is USD 6,225.6 million, representing a 50.0% market share in 2023.
Ophthalmic clinics accounted for 54.2% of the share in terms of distribution channels in 2023 and are expected to surge at a CAGR of 5.3% over the forecast period.
Collaborations and acquisitions are common strategies companies employ in the ophthalmic surgical market to enhance their capabilities, expand their offerings, and stay competitive in the market's dynamic landscape.
Leading players in the ophthalmic surgical market collaborate and form partnerships more often to take advantage of complementary skills, encourage innovation, and expand their product lines.
For instance:
The market is set to reach USD 13,937.8 million in 2024.
Demand for ophthalmic surgery is slated to expand at a 5.7% CAGR by 2034.
The market is set to reach USD 24,194.2 million in 2034.
Johnson & Johnson, Alcon Inc., and Ziemer Ophthalmic Systems AG are the key players.
Consumable segment is estimated to hold a market share of 50.0% in 2024.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. Global Market Demand (in Value or Size in USD million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 7.1. Implants 7.2. Consumable 7.3. Equipment 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Cataract Surgery 8.2. Glaucoma Surgery 8.3. Refractive Surgery 8.4. Vitreoretinal Surgery 8.5. Diabetic Retinopathy Surgery 8.6. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 9.1. Hospitals 9.2. Ophthalmic Clinics 9.3. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. North America 10.2. Latin America 10.3. East Asia 10.4. South Asia & Pacific 10.5. Western Europe 10.6. Eastern Europe 10.7. Middle East & Africa 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18. Market Structure Analysis 19. Competition Analysis 19.1. Johnson & Johnson 19.2. Alcon Inc. 19.3. Ziemer Ophthalmic Systems AG 19.4. Bausch Health (Bausch & Lomb Incorporated) 19.5. Carl-Zeiss-Stiftung (Carl Zeiss AG) 19.6. Centurion 19.7. Hoya Corporation 19.8. Canon Inc. 19.9. FCI Ophthalmic 19.10. Appasammy Associates 19.11. Corza Medical 19.12. Topcon Corporation 19.13. Coburn Technologies 19.14. Lumenis 19.15. Visionix 19.16. Glaukos Corporation 19.17. Cooper Medical Ltd 19.18. EssilorLuxottica 19.19. Nidek Co., Ltd 19.20. Staar Surgical 19.21. Quantel Medical 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports